You have searched for "exceed"

Showing 1-10 of 7399

Sort by: Newest | Oldest | Relevance


Roundup: Iran's COVID-19 cases exceed 333,000; Saudi Arabia's tally rises to 293,037

CAIRO, Aug. 12 (Xinhua) -- Iran on Wednesday said that its total COVID-19 cases reached 333,699, after reporting 2,510 new cases during the past 24 hours. Meanwhile, Saudi Arabia's tally rises to 293,037.


Ukraine to sell all but 300 state-owned enterprises: PM

KIEV, Aug. 12 (Xinhua) -- Only 300 of the more than 3,000 state-owned enterprises are to remain in state management, while others will be subject to privatization, Ukraine's Prime Minister Denys Shmyhal said on Wednesday.


O&G stocks in short-lived rally

PETALING JAYA: The recent rally in oil and gas (O&G) counters on Bursa Malaysia was short-lived as the sector’s turnaround remains sluggish with demand recovery expected to face roadblocks due to a fresh wave of coronavirus (Covid-19) infections.


Egypt reports 168 new COVID-19 cases, 95,834 in total

CAIRO, Aug. 11 (Xinhua) -- Egypt's Health Ministry reported on Tuesday 168 new COVID-19 cases, raising the total infections in the country to 95,834.


Roundup: Iran calls for enhancing anti-coronavirus cooperation in E. Mediterranean region; Saudi Arabia's COVID-19 cases exceed 290,000

CAIRO, Aug. 11 (Xinhua) -- Iran on Tuesday called for extending the cooperation on fighting COVID-19 in Eastern Mediterranean region. Meanwhile, the tally of coronavirus infections in Saudi Arabia surpassed 290,000.


Canada forward David completes record move to Lille

(Reuters) - Canada striker Jonathan David has joined Lille on a five-year contract from Belgian side Gent, the French Ligue 1 club announced on Tuesday, with media reporting that he has signed for a Canadian record 30 million euros (26.97 million pounds).

Corporate News

Bayer strikes US$875mil deal to buy women’s health biotech firm

FRANKFURT: Bayer AG struck an US$875mil deal to acquire British women’s health biotech Kandy Therapeutics Ltd in a move to expand its pharmaceuticals division before the expiration of patents on existing medicines.